enVVeno Medical Corp (NVNO)
$10.70-$0.49 (-4.36%) Today
Latest NVNO Insider Trades
Francis Duhay - DirectorOpen-market sale
Francis Duhay - DirectorFrancis Duhay - DirectorFrancis Duhay - DirectorFrancis Duhay - DirectorenVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 140 | $1K |
17 Form 4 filings on record, the earliest from Dec 20, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Francis Duhay - Director | Open-market sale | Common Stock | 140 | $10.31 | $1K | |
| Francis Duhay - Director | Open-market sale | Common Stock | 140 | $11.52 | $2K | |
| Robert Andrew Berman - Officer | Other | Restricted Stock Units | 200,000 | $0.00 | - | |
| Hamed Alavi - Officer | Other | Restricted Stock Units | 50,000 | $0.00 | - | |
| Marc H. Glickman - Officer | Other | Restricted Stock Units | 100,000 | $0.00 | - | |
| Francis Duhay - Director | Open-market sale | Common Stock | 4,900 | $12.45 | $2K | |
| Francis Duhay - Director | Open-market sale | Common Stock | 4,900 | $29.05 | $4K | |
| Sanjay Shrivastava - Director | Open-market purchase | Common Stock | 5,400 | $101.50 | $16K | |
| Matthew Jenusaitis - Director | Open-market purchase | Common Stock | 9,620 | $88.55 | $24K | |
| Robert Andrew Berman - Officer | Open-market purchase | Common Stock | 12,000 | $89.25 | $31K | |
| Marc H. Glickman - Officer | Grant or award | Stock Options | 75,000 | $0.00 | - | |
| Robert Gray - Director | Grant or award | Stock Options | 19,752 | $0.00 | - | |
| Matthew Jenusaitis - Director | Grant or award | Stock Options | 19,752 | $0.00 | - | |
| Francis Duhay - Director | Grant or award | Stock Options | 19,752 | $0.00 | - | |
| Robert Andrew Berman - Officer | Grant or award | Stock Options | 200,000 | $0.00 | - | |
| Hamed Alavi - Officer | Grant or award | Stock Options | 75,000 | $0.00 | - | |
| Sanjay Shrivastava - Director | Grant or award | Stock Options | 19,752 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
enVVeno Medical Corp (NVNO) had 1 insider filing in the last 90 days, with the most recent on 2026-06-12. The full record for NVNO runs to 17 Form 4 filings, the earliest from 2024-12-20. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of NVNO were filed in the last 90 days. 3 purchases are on record for this company.
1 insider sale of NVNO was filed in the last 90 days, totaling $1K.
This page tracks NVNO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NVNO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
